Cardiac Science Corporation wins court case for $22 million

Freeman Staff

June 8, 2015

CITY OF PEWAUKEE — Cardiac Science Corporation said Monday a 12-person jury in Los Angeles Superior Court decided in favor of the company’s breach of contract claims against Zoll Medical Corporation and Zoll LifeCor Corporation, resulting in Cardiac Science being awarded $22,991,985 in lost royalties.

City of Pewaukee-based Cardiac Science Corporation is an Opto Circuits group company and a global leader in automated external defibrillators. This case that was decided May 22 involved a long-standing dispute over the company’s wearable defibrillator technology, according to the announcement. Cardiac Science was represented by Patterson Thuente IP in the dispute.

“This decision comes after years of attempts to negotiate and resolve the dispute between the parties. Nevertheless, we are thrilled that this jury unanimously ruled that the cross-license agreement between Cardiac Science and the defendants was breached,” said Al Ford, Cardiac Science senior vice president and general manager, in a statement.

According to the announcement, in 2002 LifeCor began marketing its LifeVest product, which Cardiac Science alleged infringed a number of Cardiac Science’s patents. To avoid infringement claims, LifeCor entered into a cross-license agreement with Cardiac Science and was able to continue selling its device, according to the company; however, once Zoll Medical acquired LifeCor in 2006, they stopped paying royalties associated with the cross-license agreement. Cardiac Science sued Zoll Medical and Zoll LifeCor for breach of contract in 2011.

www.cardiacscience.com